.

BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Merck
Dow
Colorcon
Cantor Fitzgerald
Chubb
AstraZeneca
QuintilesIMS
Novartis
Teva

Generated: November 20, 2017

DrugPatentWatch Database Preview

Armodafinil - Generic Drug Details

« Back to Dashboard

What are the generic sources for armodafinil and what is the scope of armodafinil patent protection?

Armodafinil
is the generic ingredient in two branded drugs marketed by Mylan Pharms Inc, Lupin Ltd, Watson Labs Inc, Natco Pharma Ltd, and Cephalon, and is included in five NDAs. There are two patents protecting this compound and two Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.

There are twelve drug master file entries for armodafinil. Thirteen suppliers are listed for this compound. There are four tentative approvals for this compound.

Tentative approvals for ARMODAFINIL

Applicant Application No. Strength Dosage Form
u► Subscribe50MGTABLET;ORAL
u► Subscribe250MGTABLET;ORAL
u► Subscribe200MGTABLET;ORAL
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Cephalon
NUVIGIL
armodafinil
TABLET;ORAL021875-004Jun 15, 2007ABRXYesYes► Subscribe► SubscribeY► Subscribe
Lupin Ltd
ARMODAFINIL
armodafinil
TABLET;ORAL200751-003Nov 28, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
Cephalon
NUVIGIL
armodafinil
TABLET;ORAL021875-005Mar 26, 2009ABRXYesNo► Subscribe► SubscribeY► Subscribe
Cephalon
NUVIGIL
armodafinil
TABLET;ORAL021875-001Jun 15, 2007ABRXYesNo► Subscribe► SubscribeY► Subscribe
Mylan Pharms Inc
ARMODAFINIL
armodafinil
TABLET;ORAL200043-003Jun 1, 2012ABRXNoNo► Subscribe► Subscribe► Subscribe
Cephalon
NUVIGIL
armodafinil
TABLET;ORAL021875-003Jun 15, 2007ABRXYesNo► Subscribe► SubscribeY► Subscribe
Cephalon
NUVIGIL
armodafinil
TABLET;ORAL021875-002Mar 26, 2009DISCNYesNo► Subscribe► SubscribeY► Subscribe
Cephalon
NUVIGIL
armodafinil
TABLET;ORAL021875-001Jun 15, 2007ABRXYesNo► Subscribe► SubscribeY► Subscribe
Watson Labs Inc
ARMODAFINIL
armodafinil
TABLET;ORAL200156-002Aug 29, 2012DISCNNoNo► Subscribe► Subscribe► Subscribe
Cephalon
NUVIGIL
armodafinil
TABLET;ORAL021875-002Mar 26, 2009DISCNYesNo► Subscribe► SubscribeY► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: armodafinil

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Cephalon
NUVIGIL
armodafinil
TABLET;ORAL021875-005Mar 26, 2009► Subscribe► Subscribe
Cephalon
NUVIGIL
armodafinil
TABLET;ORAL021875-001Jun 15, 2007► Subscribe► Subscribe
Cephalon
NUVIGIL
armodafinil
TABLET;ORAL021875-002Mar 26, 2009► Subscribe► Subscribe
Cephalon
NUVIGIL
armodafinil
TABLET;ORAL021875-003Jun 15, 2007► Subscribe► Subscribe
Cephalon
NUVIGIL
armodafinil
TABLET;ORAL021875-004Jun 15, 2007► Subscribe► Subscribe
Cephalon
NUVIGIL
armodafinil
TABLET;ORAL021875-003Jun 15, 2007► Subscribe► Subscribe
Cephalon
NUVIGIL
armodafinil
TABLET;ORAL021875-002Mar 26, 2009► Subscribe► Subscribe
Cephalon
NUVIGIL
armodafinil
TABLET;ORAL021875-004Jun 15, 2007► Subscribe► Subscribe
Cephalon
NUVIGIL
armodafinil
TABLET;ORAL021875-005Mar 26, 2009► Subscribe► Subscribe
Cephalon
NUVIGIL
armodafinil
TABLET;ORAL021875-001Jun 15, 2007► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Dow
McKinsey
Queensland Health
Boehringer Ingelheim
Teva
Chubb
Chinese Patent Office
Cipla
US Army
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot